Evidence map›Paper›PMID 28860313›Full record

ArticleCirculation research2017

Smooth Muscle Differentiation Control Comes Full Circle: The Circular Noncoding RNA, circActa2, Functions as a miRNA Sponge to Fine-Tune α-SMA Expression.

Mary C M Weiser-Evans

Abstract readEditorialComment
In one paragraph

Article in Circulation research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Contribution of Gli1Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Circular RNAs in cardiovascular diseases.Pharmacology & therapeutics · 2022
    Review
  6. Review
  7. Article
  8. Review
  9. Circular RNAs: Expression, localization, and therapeutic potentials.Molecular therapy : the journal of the American Society of Gene Therapy · 2021
    Review
  10. Review
  11. Review
  12. mCell research · 2020
    Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Mary C M Weiser-EvansFrom the Division of Renal Diseases and Hypertension, Department of Medicine, Cardiovascular Pulmonary Research Program and Division of Cardiology, School of Medicine, Consortium for Fibrosis Research and Translation, University of Colorado, Anschutz Medical Campus, Aurora. mary.weiser@ucdenver.edu.

Funding

Reprogramming of mature smooth muscle cells to vascular progenitor cellsR01HL121877 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI MARK W. MAJESKY, Mary CM Weiser-Evans · 2015 to 2026
$7.8M
PTEN-dependent regulation of SRF transcriptional activity and SMC phenotype controlR01HL123616 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI WEISER-EVANS, MARY CM. · 2015 to 2018
$2.0M
NHLBI NIH HHS R01 HL121877NHLBI NIH HHS R01 HL123616
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MicroRNAsActinsCell DifferentiationMuscle, SmoothMyocytes, Smooth MuscleActinsMicroRNAsangioplastyEditorialshomeostasismyocardinneuregulin-1serum response factor

Identifiers

PMID28860313
PMCPMC5679083

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.